Two years away from clinical trials, the method targets the T-cell in the immune system - offering patients the possibility of a treatment beyond medication and its side effects.
The hormone testosterone may play an important role in the development of endometrial cancer, raising new possibilities for screening, preventing and fighting the disease.
The new vaccine candidate offers a breakthrough approach that combines two powerful arms of the immune system to target Epstein–Barr virus in both acute and latent infection.